These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37810906)

  • 1. Temporal evolution of laboratory characteristics in patients critically ill with COVID‑19 admitted to the intensive care unit (Review).
    Kokkoris S; Kanavou A; Kremmydas P; Katsaros D; Karageorgiou S; Gkoufa A; Georgakopoulou VE; Spandidos DA; Giannopoulos C; Kardamitsi M; Routsi C
    Med Int (Lond); 2023; 3(5):52. PubMed ID: 37810906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in laboratory parameters in survivors and non‑survivors of critical COVID‑19 illness and the effect of dexamethasone treatment.
    Kokkoris S; Kanavou A; Katsaros D; Karageorgiou S; Kremmydas P; Gkoufa A; Ntaidou T; Giannopoulos C; Kardamitsi MA; Dimopoulou G; Theodorou E; Georgakopoulou VE; Spandidos DA; Orfanos S; Kotanidou A; Routsi C
    Biomed Rep; 2024 Jan; 20(1):12. PubMed ID: 38124763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
    Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
    BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Laboratory Profile of COVID-19 Pneumonia Patients With a Complicated Post-Intensive Care Unit Hospital Course.
    Yaqoob H; Vernik D; Feustel PJ; Chandy D; Epelbaum O
    J Clin Med Res; 2021 Nov; 13(10-11):487-496. PubMed ID: 34925659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave.
    Banno A; Hifumi T; Okamoto H; Masaki M; Seki K; Isokawa S; Otani N; Hayashi K; Ishimatsu S
    BMC Infect Dis; 2021 Feb; 21(1):163. PubMed ID: 33563218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
    Sepulchre E; Pittie G; Stojkovic V; Haesbroek G; Crama Y; Schyns M; Paridaens H; de Marchin J; Degesves S; Biemar C; Boccar S; Senterre JM; Minon JM
    Acta Clin Belg; 2022 Apr; 77(2):261-267. PubMed ID: 32935644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.
    Jamous F; Meyer N; Buus D; Ateeli H; Taggart K; Hanson T; Alzoubaidi M; Nazir J; Devasahayam J
    S D Med; 2020 Jul; 73(7):312-317. PubMed ID: 32805781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units.
    Zanella A; Florio G; Antonelli M; Bellani G; Berselli A; Bove T; Cabrini L; Carlesso E; Castelli GP; Cecconi M; Citerio G; Coloretti I; Corti D; Dalla Corte F; De Robertis E; Foti G; Fumagalli R; Girardis M; Giudici R; Guiotto L; Langer T; Mirabella L; Pasero D; Protti A; Ranieri MV; Rona R; Scudeller L; Severgnini P; Spadaro S; Stocchetti N; Viganò M; Pesenti A; Grasselli G;
    Intensive Care Med; 2021 Sep; 47(9):995-1008. PubMed ID: 34373952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological characteristics, baseline clinical features, and outcomes of critically ill patients treated in a coronavirus disease 2019 tertiary center in continental Croatia.
    Čučković M; Drmić Ž; Pražetina M; Tipura D; Ćurčić M; Miko I; Mihelčić A; Romić A; Kukoč A; Blagaj V; Lasić H; Dolenc E; Hleb S; Almahariq H; Šribar A; Peršec J; Lukšić I
    Croat Med J; 2022 Feb; 63(1):6-15. PubMed ID: 35230001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Profile of Prognostic Hematologic Indicators in Patient Under Intensive Care for COVID-19 Disease: A One-Year Study at a Tertiary Care Centre in South India.
    Balasubramanian J; Suman FR; Stephen IR; Shanmugam SG; Mani R; Mathan B; P L
    Cureus; 2021 Nov; 13(11):e19585. PubMed ID: 34926056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical Parameters as Prognostic Markers in Severely Ill COVID-19 Patients.
    Pitamberwale A; Mahmood T; Ansari AK; Ansari SA; Limgaokar K; Singh L; Karki G
    Cureus; 2022 Aug; 14(8):e28594. PubMed ID: 36185918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients.
    Ilias I; Diamantopoulos A; Botoula E; Athanasiou N; Zacharis A; Tsipilis S; Jahaj E; Vassiliou AG; Vassiliadi DA; Kotanidou A; Tsagarakis S; Dimopoulou I
    Front Endocrinol (Lausanne); 2021; 12():644055. PubMed ID: 34220703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study.
    Neethling C; Calligaro G; Miller M; Opie JJS
    Thromb J; 2021 Nov; 19(1):83. PubMed ID: 34742307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of critically ill coronavirus disease 2019 patients in Malaysia during the first wave: A multi-center observational study (COVIDICU-MY).
    Ab Rahman NI; Yunos NM; Atan R; Mariapun J; Ab Rahman MA; Ismail AJ; Deva SR
    Front Med (Lausanne); 2022; 9():1086288. PubMed ID: 36698832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
    Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
    Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine laboratory parameters in estimating mortality and morbidity in COVID-19 diagnosed cases followed in the intensive care unit.
    Kutlusoy S; Koca E
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5885-5892. PubMed ID: 37401326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Intensive Care Unit Admission for COVID-19 Patients from Laboratory Results.
    Azad Allarakia BM; Gattan HS; Abdeen RH; Al-Ahmadi BM; Shater AF; Bazaid MB; Althomali OW; Bazaid AS
    Dis Markers; 2022; 2022():4623901. PubMed ID: 35634446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.
    Montrucchio G; Sales G; Balzani E; Lombardo D; Giaccone A; Cantù G; D'Antonio G; Rumbolo F; Corcione S; Simonetti U; Bonetto C; Zanierato M; Fanelli V; Filippini C; Mengozzi G; Brazzi L
    Front Med (Lausanne); 2023; 10():1122367. PubMed ID: 37035317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased maternal mortality in unvaccinated SARS-CoV-2 infected pregnant patients.
    Atak Z; Rahimli Ocakoglu S; Topal S; Macunluoglu AC
    J Obstet Gynaecol; 2022 Oct; 42(7):2709-2714. PubMed ID: 35852931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.
    Bolondi G; Russo E; Gamberini E; Circelli A; Meca MCC; Brogi E; Viola L; Bissoni L; Poletti V; Agnoletti V
    World J Emerg Surg; 2020 Jun; 15(1):41. PubMed ID: 32605582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.